Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Labetalol.

Drug Intelligence & Clinical Pharmacy

|October 1, 1983

Summary

This summary is machine-generated.

Labetalol effectively treats hypertension by blocking alpha and beta receptors, lowering blood pressure with minimal impact on cardiac output. It offers benefits over other beta-blockers, especially when vasodilation is also needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Health sequelae of human cryptosporidiosis-a 12-month prospective follow-up study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2019

Same author

Mating factor dependence of G1 cell cycle mutants of Saccharomyces cerevisiae.

Current genetics·2013

Same author

Indication-specific 6-h systolic blood pressure thresholds can approximate 24-h determination of blood pressure control.

Journal of human hypertension·2010

Same author

Delayed elimination of theophylline in pregnancy.

Canadian Medical Association journal·2010

Same author

[Improving blood pressure control with physician/pharmacist collaboration].

Vnitrni lekarstvi·2009

Same author

Development of explicit criteria to measure adherence to hypertension guidelines.

Journal of human hypertension·2006

Same journal

Profile of prescription medication in a pediatric population.

Drug intelligence & clinical pharmacy·1988

Same journal

SI units in drug therapeutics.

Drug intelligence & clinical pharmacy·1988

Same journal

Physicians' review of significant interventions by clinical pharmacists in inpatient care.

Drug intelligence & clinical pharmacy·1988

Same journal

Possible interaction of ranitidine with phenytoin.

Drug intelligence & clinical pharmacy·1988

Same journal

Famotidine-associated mental confusion in elderly patients.

Drug intelligence & clinical pharmacy·1988

Same journal

Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

Drug intelligence & clinical pharmacy·1988

See all related articles

Area of Science:

Pharmacology
Cardiovascular Medicine

Background:

Labetalol is an adrenergic receptor antagonist.
It blocks alpha 1-, beta 1-, and beta 2-adrenergic receptors.

Purpose of the Study:

To evaluate the efficacy and hemodynamic effects of labetalol in treating hypertension.
To compare labetalol with other antihypertensive agents.

Main Methods:

Review of open trials and controlled studies on labetalol.
Analysis of hemodynamic parameters including blood pressure, heart rate, cardiac output, and stroke volume.

Main Results:

Labetalol effectively reduces blood pressure and peripheral resistance.
Hemodynamic effects include reduced heart rate and blood pressure with minimal changes in cardiac output.

Related Experiment Videos

Intravenous labetalol rapidly lowers blood pressure in severe hypertension.

Labetalol showed favorable comparisons with other beta-blockers and vasodilators.

Conclusions:

Labetalol is an effective antihypertensive agent, particularly useful when vasodilation is desired or for patients experiencing side effects from other beta-blockers.
Further research is needed to fully define its clinical profile.